Rayzebio Inc
(RYZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 50,566 |
| Marketable Securities | 148,600 |
| Other current assets | 3,261 |
| TOTAL | $202,427 |
| Non-Current Assets | |
| PPE Net | 6,052 |
| Other Non-Current Assets | 385 |
| TOTAL | $6,437 |
| Total Assets | $216,385 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 1,127 |
| Accrued Expenses | 3,159 |
| TOTAL | $6,135 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 257,615 |
| TOTAL | $257,615 |
| Total Liabilities | $270,959 |
| Shareholders' Equity | |
| Retained earnings | -55,106 |
| Other shareholders' equity | -239 |
| TOTAL | $-54,574 |
| Total Liabilities And Equity | $216,385 |